The SQDC reports net income of $94.9 million for fiscal 2022-2023

What Can Investors Learn from Canopy Growth's Downfall? - TDR Exclusive $CGC

“I’m not sure if we could, given the composition of this Congress, that we can get anything passed that would make sense,” she said. “We probably should have done it last year when [Democrats] were in control, but we didn’t.”

"soon"

Critics question whether Biden-signed marijuana research law has ‘any value’

Citadel, Susquehanna, and K2 are making bank by shorting $CGC with 1M+ of puts for each of them 📉

Legalized weed isn’t working, blame voters for 2024 trainwreck and other commentary

Why this is a make-or-break year for Canada’s cannabis industry

This Beaten Up Cannabis ETF Is Not Attractive $MSOS "MSOS is down a lot, but we don't think investors should buy it. For those that can buy its holdings, we think some of them are a much better bet."

$CXXI deserves more respect. In a sector full of cash-burning shitcos, this is one of the few financially-responsible company that stands out from the rest along with $GTII

Acreage CEO and CFO resigned 🚩 $ACRGF $CGC

Cannabis price 'race to the bottom' hurts market's future: OCS CEO

This is what a desperate bagholder looks like. @bellogram2 calls others "beta males" and "feminine" but can't even assume his own responsibility for his losses like a grown-up man. He tries to sound smart and confident until you start fact-checking the bullshit he's spewing.

Delusional bagholder quote

$TLRY chose dilution instead of using the cash on the balance sheet to pay down debt. Why? Because they want to continue overpaying to buy more money-losing companies like $HEXO Result: 20% loss in market cap for convertible notes that would have caused only 10% share dilution🤦‍♂️

For those interested, I went back on the CIN podcast to cover the big 5 MSOs' results through the first quarter of 2023. Big focus was on market footprints and diving deep into cash flow dynamics and balance sheet strength

Just a reminder that "Doing Your Own Due Diligence" also includes fact-checking the bullshit you are fed by other people on the internet.

Does suggest the potential if a larger operator could buy out and pay down debt (not sure what the stipulations are on early debt paydown). Florida, even with price compression, clearly still a very valuable market to operate in with scale

64% gross margins, 44% aEBITDA margins and healthy growth. Debt on the balance sheet is a killer though- $5.1M in OCF adjusted for taxes and IFRS lease payments means actual OCF was $448k. Q1 Interest payment ($4.25M) is roughly the same as what GTI pays

Viridian Capital Chart of the Week: Pushing the Limits of Debt Financing – Time for Investors to be Careful

Two Dozen Publicly Traded U.S. Cannabis Companies Lost $4 Billion Last Year

Not bad for @GTIGrows @veranobrands @crescolabs @AscendHoldings @Curaleaf_Inc, all of whom are easily north of $100M coming from IL annually

Canopy Growth asks S&P Global to pull credit ratings

Not ready for the last episode ever of Succession 🥺

More than 90% of Calif. pot farms infected with ‘severe’ pathogen

Tilray has entered into a share lending agreement with Jefferies LLC, which will see the company lend 38.5 million shares to the investment bank. The shares are to be newly issued, which Tilray expects to be used to enter a short position. $TLRY

Tilray Brands, Inc. Announces Proposed Registered Offering of $150 Million of Convertible Senior Notes $TLRY

Some people said the upside potential outweighs the downside risk when the stock price is low, so I will just leave this here. $CGC is down -15% in a single day even after losing 98% of its value, and it could continue infinitely with reverse splits.

I should have just kept $NVDA as my largest position 😅

Every time someone attempts to make a bull thesis on cannabis stocks it always comes down to "if this thing happens then stocks will go to the moon"... Yeah ok, I'll just wait for the news then I'll get back in, but until that happens nothing will bring new buyers. #JustWaitForIt

I notice a regain of optimism from cannabis investors but what has changed fundamentally? The main problems remain - no catalyst and no new buyers. I have not seen a single bullish argument that is not based on contrarian speculation or betting on unpredictable political outcomes

$CGC $0.97 💩

Deal makes perfect sense on paper (good operator w/ limited footprint in CL + a poor operator w/ an expansive footprint in CC means 1+1=3), but deteriorating market conditions have sent asset prices plummeting meaning there isn't enough to paydown combined debt sufficiently imho

Discussions around the CC merger are still top of mind as both companies continue to struggle on their own. Personally thought management showed more hesitancy than ever regarding the prospects of it closing, outlining several obstacles needed to overcome

Mixed Q1 from @crescolabs, with better cost control and a small beat on top-line expectations, but also limited growth prospects on their own and an inability to inflect towards meaningful cash generation with a relatively weak margin profile.

Constellation Brands Market Cap: $43 billion Canopy Growth Market Cap: $0.5 billion USD Bruce was this 🤏 close

Congressional Committee Blocks GOP-Led Marijuana Legalization And Fentanyl Contamination Amendments From Floor Votes

Subscription sellers be like

Viridian Capital Chart of the Week: Does the Lack of Trading Liquidity Inhibit Capital Raising?

Senator, Federal Officials And Consumer Groups Sound Alarm Over Marijuana Banking Bill Provision That Could Undermine Financial Regulators

Modest improvement in Q1 from @Curaleaf_Inc, with more still needed to inflect towards sustained profitability and CF. The good: beat consensus as west coast exits reduced OpEx and enhanced margins. The bad: tax-adjusted CF still negative with the BS increasingly looking thin

Colorado House Approves Bill To Let Doctors Prescribe Psilocybin After Federal Approval

More American Adults Use Cannabis As A Sleep Aid Than Choose Prescription Pills Or Alcohol To Fall Asleep, Poll Shows

Indiana Lawmakers Look To Michigan And Illinois As Guides For How To Legalize Marijuana With The Right Regulations

Pennsylvania’s GOP Attorney General Warns Of ‘Potential Harms’ Of Marijuana Legalization Amid Bipartisan Push For Reform In 2025

Virginia Senate Panel Advances Proposal To Fund Psychedelic Therapy Trials And Pave Path To Broader Reform

FDA Wants To Add Hemp-Derived Cannabinoid Product Option To Federal Form About Negative Consumer Experiences

Idaho House Passes Bill To Set Mandatory Minimum Fine For Marijuana Possession

Trump Pardons Silk Road Drug Market Operator Russ Ulbricht, Despite Calling For Execution Of Drug Sellers

Trump’s AG dodges cannabis questions from senators (Newsletter: January 22, 2025)

Wynk Expands into Florida, Bringing its Buzzy Hemp-Derived THC Seltzer to the Sunshine State’s Dynamic Market

Massachusetts Lawmakers Filed A Dozen Psychedelics-Related Bills Ahead Of Last Week’s Legislative Deadline

New Missouri Rules Target Marijuana Business License Middlemen In Effort To Limit ‘Predatory’ Practices

IRS Clarifies How Newly Finalized Tax Rules For Certain Insurers Impact Marijuana Businesses

Trump’s New DEA Head Blamed Marijuana For School Shootings And Claimed Rescheduling Push Was Politically Motivated

Congressional Researchers Outline ‘Diverging’ Priorities For Federal Hemp Laws Under Trump Administration

Canceled Marijuana Rescheduling Hearings Would Have Shut Out People Impacted By Criminalization (Op-Ed)

Trump’s Pick For Attorney General Refuses To Say Where She Stands On Marijuana Rescheduling Or Federal Enforcement Priorities

Former DEA official who calls cannabis a “gateway drug” could be Trump’s pick (Newsletter: January 21, 2025)

Former DEA Official Who Says Marijuana Is A ‘Gateway Drug’ And Confused Agency’s Scheduling Role Claims Trump Allies Want Him As Administrator

Virginia Crime Commission Says All Marijuana Possession Records Should Be Sealed

Elizabeth Warren Presses RFK Jr. On Marijuana Legalization And How He Would Handle Rescheduling As Trump’s Health Secretary

Missouri Lawmakers Push To Legalize Psilocybin For Mental Health Conditions And End-Of-Life Care

U.S. Border Agency Urges Court To Dismiss New Mexico Marijuana Businesses’ Lawsuit Over Seizures Of State-Legal Products Because ‘Federal Law Prevails’

Federal Health Officials Revise Marijuana-Related Terminology To Reflect More Nuanced View Of Cannabinoids Like THCA And Delta-8 THC

The Florida Cannabis Market Is Struggling

Cannabis rescheduling back in DEA leader’s hands (Newsletter: January 20, 2025)

Marijuana, Cocaine And Heroin: Three Drugs That Started Legal, Became Banned And Were Then Used In Medicines

Marijuana Trade Group Pushes Back On Proposed Missouri Rules To Combat ‘Predatory’ Business Practices

Florida County Asks Appeals Court For Permission To Fire EMT Over Medical Marijuana Use

Biden Commutes Sentences Of Nearly 2,500 People In Prison For Drug Offenses, Including Some Who Are Locked Up On Marijuana Charges

Kentucky Governor Slams Federal Marijuana Ban, Saying Medical Cannabis Patients Shouldn’t Lose Gun Rights

DEA Judge Notifies Agency Head About Marijuana Rescheduling Hearing Cancelation Following Appeal Order

President Biden Commutes Nearly 2,500 Drug Convictions

Cheba Hut ‘Toasted’ Subs Partners with Last Prisoner Project to Help Those Affected by Cannabis Prohibition

Treasury Secretary Yellen Says First Time Smoking Marijuana Was ‘OK’ And She’d Recommend ‘Delicious’ Psychedelic Mushrooms She Ate

Virginia Senate Committee Advances Bill To Legalize Marijuana Sales Despite Governor’s Opposition

Indiana’s Republican Governor Is ‘Amenable’ To Medical Marijuana Legalization Even As Top GOP Lawmakers Oppose It

Ilhan Omar Says New Cannabis Caucus Chairs Will Be ‘Louder’ And Appeal To GOP’s ‘Libertarian Senses’ To Advance Reform In 2025

Feds spotlight cannabis industry workers’ risks from allergens (Newsletter: January 17, 2025)

Federal OSHA Officials Spotlight Marijuana And Hemp Industry Workers’ Risks From Allergens

Ohio GOP House Speaker Says Nobody Plans To Repeal Marijuana Legalization Law, While Backpedaling On Home Grow Opposition

Colorado Springs To Move Forward With Legal Marijuana Sales Even As Some City Leaders Plan Renewed Ban

Why Delaying DEA’s Biased Marijuana Rescheduling Hearing Is Good For The Cannabis Industry (Op-Ed)

Leading Marijuana Industry Groups Merge To Unite Push For Federal Reform And Stock Market Access Under Trump Administration

Idaho Lawmakers Approve Bill To Set Mandatory Minimum Fine For Marijuana Possession

Not So High Times

Massachusetts Marijuana Officials Say Social Consumption Plan Will Position State As East Coast Industry Leader (Op-Ed)

Justice Department Says Marijuana Rescheduling Case Should Be Paused In Federal Court After DEA Cancels Hearings

Federal official floats government cannabis sales monopoly (Newsletter: January 16, 2025)

FDA Seeks Veterinarians’ Input On Use Of CBD And Other Cannabis Products In Animals